Does a 2-h gap beat 15 h for the lactate curve?
In 14 active men over 3 weeks the curve shifted right in both arms, no clear difference. Very likely Ghiarone 2019's men, not a new trial. Not doubles against singles.
This analysis comes from the project that produced Ghiarone 2019 (REF-1535) and Andrade-Souza 2020 (REF-1536). In Study 1, five randomly chosen participants did three trials in randomised order.
A 100-min ride plus six 1-min sprints came 15 h before an interval session (once-daily), about 2 h before it (twice-a-day), or not at all (control); the interval session was the same in all, ten 2-min bouts with a low-carbohydrate breakfast beforehand. MCT1 mRNA at 3 h was about 80% higher after twice-a-day than once-daily (P = .038).
It also rose in the control (P = .046), and twice-a-day was not significantly above the control. MCT4 did not change. In Study 2, 14 men trained for 3 weeks, the same two sessions as a pair, 2 h apart on three days a week or 15 h apart across six days a week.
A graded test before and after showed the lactate curve further right in both groups: slope index 0.60 ± 0.59 to 0.11 ± 0.07 and 0.56 ± 0.75 to 0.10 ± 0.07 mmol/L/min, time effect P = .007, group × time P = .609. Our reading: the gene signal differed acutely and the lactate curve did not clearly differ after training.
The title's "does not change the lactate curve" does not match the results: the curve changed in both arms; what did not clearly differ was the change between them.
Protocol
Key Results
| Study 2 measure | Once-daily (n = 7): pre → post | Twice-a-day (n = 7): pre → post | Group × time P (ηp2) | Time P |
|---|---|---|---|---|
| Lactate slope index (mmol/L/min) | 0.60 ± 0.59 → 0.11 ± 0.07 | 0.56 ± 0.75 → 0.10 ± 0.07 | .609 (0.02) | .007 |
| Exercise duration in the graded test (min) | 41.6 ± 4.4 → 47.5 ± 4.9 | 42.4 ± 7.6 → 49.5 ± 8.7 | .189 (0.14) | < .01 |
| Peak plasma lactate (mmol/L) | 10.4 ± 1.3 → 11.0 ± 1.5 | 9.2 ± 2.7 → 10.6 ± 2.6 | .276 (0.10) | < .01 |
| Study 1 measure (n = 5) | Result | P |
|---|---|---|
| MCT1 mRNA, condition × moment | .046 (ηp2 0.44) | |
| MCT1, 3 h, twice-a-day vs once-daily | about 80% higher | .038 |
| MCT1, 3 h vs pre, control | higher (about 106% in the discussion) | .046 |
| MCT1, 3 h, twice-a-day vs control | about 50% higher, not significant | |
| MCT4 mRNA, condition × moment | no change | .252 (ηp2 0.27) |
Mechanisms
Practical Application
Limitations
How this entry was checked and changed
a parallel RCT under 20 earns B (rubric), lowered one step: the data are a posteriori with sample size set for other outcomes, the outcome is a lactate curve parameter rather than performance, and the acute part has 5 men. Read from the full text (CC BY). Not independent of REF-1535 and REF-1536: the paper cites both as reports of its umbrella project. It also recruited 15 men on the protocol of REF-1535, whose 8 and 7 fit 7 and 7 after one exclusion, so they are very likely the same men (our inference; no sentence says so). The three count as one project, not three independent tests